SEC of CDSCO has recommended for upgrade of covishield and covaxin status from restricted use in emergency situations to grant of new drug permission with conditions In adult population ,DCGI will evaluate the recommendations and give its decision.

— CDSCO_INDIA_INFO (@CDSCO_INDIA_INF) January 19, 2022